kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 200mg - sarilumab 200mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 150mg - sarilumab 150mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 200mg - sarilumab 200mg - disease-modifying antirheumatic agents
yescarta suspension
gilead sciences canada inc - axicabtagene ciloleucel - suspension - 200000000cellules - axicabtagene ciloleucel 200000000cellules - antineoplastic agents
abecma suspension
celgene inc - idécabtagène vicleucel - suspension - 520000000cellules - idécabtagène vicleucel 520000000cellules - gene therapy
tecartus suspension
gilead sciences canada inc - brexucabtagène autoleucel - suspension - 200000000cellules - brexucabtagène autoleucel 200000000cellules - antineoplastic agents
breyanzi suspension
celgene inc - lisocabtagène maraleucel - suspension - 120000000cellules - lisocabtagène maraleucel 120000000cellules
tecartus suspension
gilead sciences canada inc - brexucabtagène autoleucel - suspension - 100000000cellules - brexucabtagène autoleucel 100000000cellules
columvi solution
hoffmann-la roche limited - glofitamab - solution - 10mg - glofitamab 10mg
columvi solution
hoffmann-la roche limited - glofitamab - solution - 2.5mg - glofitamab 2.5mg